MetLife Investment Management’s CATALENT, INC. CTLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-47,055
| Closed | -$2.85M | – | 2875 |
|
|
2024
Q3 | $2.85M | Sell |
47,055
-1,213
| -3% | -$71.8K | 0.02% | 828 |
|
|
2024
Q2 | $2.71M | Buy |
48,268
+5,970
| +14% | +$333K | 0.02% | 837 |
|
|
2024
Q1 | $2.39M | Sell |
42,298
-1,451
| -3% | -$78.6K | 0.02% | 880 |
|
|
2023
Q4 | $1.97M | Sell |
43,749
-829
| -2% | -$33.5K | 0.01% | 955 |
|
|
2023
Q3 | $2.03M | Sell |
44,578
-1,122
| -2% | -$52.4K | 0.02% | 898 |
|
|
2023
Q2 | $1.98M | Sell |
45,700
-3,025
| -6% | -$133K | 0.01% | 935 |
|
|
2023
Q1 | $3.2M | Sell |
48,725
-519
| -1% | -$32.1K | 0.02% | 705 |
|
|
2022
Q4 | $2.22M | Sell |
49,244
-403
| -0.8% | -$21.9K | 0.02% | 865 |
|
|
2022
Q3 | $3.59M | Sell |
49,647
-678
| -1% | -$67.3K | 0.03% | 585 |
|
|
2022
Q2 | $5.4M | Sell |
50,325
-13
| -0% | -$1.32K | 0.04% | 379 |
|
|
2022
Q1 | $5.58M | Buy |
50,338
+12,517
| +33% | +$1.31M | 0.04% | 453 |
|
|
2021
Q4 | $4.84M | Sell |
37,821
-651
| -2% | -$83.7K | 0.04% | 416 |
|
|
2021
Q3 | $5.12M | Sell |
38,472
-1,020
| -3% | -$127K | 0.05% | 352 |
|
|
2021
Q2 | $4.27M | Sell |
39,492
-1,072
| -3% | -$115K | 0.04% | 470 |
|
|
2021
Q1 | $4.27M | Buy |
40,564
+567
| +1% | +$63.2K | 0.04% | 470 |
|
|
2020
Q4 | $4.16M | Sell |
39,997
-1,619
| -4% | -$157K | 0.04% | 438 |
|
|
2020
Q3 | $3.56M | Sell |
41,616
-54,973
| -57% | -$4.65M | 0.04% | 445 |
|
|
2020
Q2 | $7.08M | Buy |
96,589
+7,758
| +9% | +$527K | 0.08% | 210 |
|
|
2020
Q1 | $4.61M | Buy |
88,831
+4,848
| +6% | +$265K | 0.06% | 280 |
|
|
2019
Q4 | $4.73M | Sell |
83,983
-948
| -1% | -$48.3K | 0.05% | 376 |
|
|
2019
Q3 | $4.05M | Sell |
84,931
-1,399
| -2% | -$75.2K | 0.04% | 432 |
|
|
2019
Q2 | $4.68M | Sell |
86,330
-2,443
| -3% | -$112K | 0.05% | 378 |
|
|
2019
Q1 | $3.6M | Buy |
88,773
+132
| +0.1% | +$5.16K | 0.04% | 514 |
|
|
2018
Q4 | $2.76M | Sell |
88,641
-55
| -0.1% | -$2.12K | 0.03% | 599 |
|
|
2018
Q3 | $4.04M | Buy |
88,696
+4,874
| +6% | +$206K | 0.04% | 469 |
|
|
2018
Q2 | $3.51M | Sell |
83,822
-59,983
| -42% | -$2.42M | 0.04% | 512 |
|
|
2018
Q1 | $5.91M | Sell |
143,805
-864
| -0.6% | -$36.8K | 0.07% | 268 |
|
|
2017
Q4 | $5.94M | Buy |
+144,669
| New | +$5.89M | 0.07% | 276 |
|
Other funds holding CTLT
RAM
IA
EBA
HNB
MetLife Investment Management's CTLT Position: Q4 2024 in Review
MetLife Investment Management sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 47,055 shares — an estimated $2.85M sold.
MetLife Investment Management first reported a position in CTLT in Q4 2017 and held it in 28 quarters. The position peaked at $7.08M in Q2 2020. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.
- MetLife Investment Management reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
- MetLife Investment Management sold 47,055 CATALENT, INC. shares in Q4 2024, an estimated $2.85M.
- MetLife Investment Management first reported a position in CATALENT, INC. in Q4 2017 and held it in 28 quarters.
- MetLife Investment Management's CATALENT, INC. position peaked at $7.08M in Q2 2020.
- 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.
Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.